1
|
Teske AJ, Jimenez-Rodriguez GM, Kraaijeveld AO, Broekhuizen LN, van Osch D, Gort EH, Rhenen AV, Harst PV, Voskuil M. Intracardiac echocardiography-guided biopsies for right-sided intracardiac tumors: An optimized diagnostic algorithm and case illustrations. Catheter Cardiovasc Interv 2024; 104:862-868. [PMID: 39162288 DOI: 10.1002/ccd.31189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/12/2024] [Revised: 06/27/2024] [Accepted: 08/07/2024] [Indexed: 08/21/2024]
Abstract
Intracardiac tumors, though uncommon, necessitate a swift and accurate diagnosis for personalized treatment and prognosis estimation. While multi-modality imaging often determines the etiology of these cardiac masses, histological confirmation remains essential for definitive diagnosis and its specific treatment. Since cardiac tumors are often found in high-risk locations (ventricular free wall or atria), precision biopsy is paramount. The least invasive strategy would be to achieve this by means of endomyocardial biopsy (EMB); however real-time additional imaging is essential to reduce the risk of perforation/tamponade and to minimize sampling error. Intracardiac echocardiography (ICE) emerges as an excellent tool to achieve this goal preventing procedural complications and reducing the likelihood of sampling errors obtaining a definitive histopathological diagnosis in all cases. This paper outlines our diagnostic algorithm for optimal patient selection, details three illustrative cases, and elucidates the steps to acquire histopathology via percutaneous transvenous biopsy with ICE guidance in patients with right-sided cardiac tumors. Given the rarity of intracardiac tumors, we advocate these patients be managed by a dedicated multidisciplinary cardio-oncology team including an interventional cardiologist.
Collapse
Affiliation(s)
- Arco J Teske
- Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands
| | - Gian-Manuel Jimenez-Rodriguez
- Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands
- Department of Interventional Cardiology , National Institute of Cardiology, Ignacio Chavez, Mexico City, Mexico
| | - Adriaan O Kraaijeveld
- Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands
| | - Lysette N Broekhuizen
- Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands
- Department of Cardiology , Central Military Hospital, Utrecht, The Netherlands
| | - Dirk van Osch
- Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands
| | - Eelke H Gort
- Department of Medical Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands
| | - Anna V Rhenen
- Department of Hematology, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands
| | - Pim Vd Harst
- Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands
| | - Michiel Voskuil
- Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands
| |
Collapse
|
2
|
Nistor C, Stanciu Gavan C, Birceanu A, Betianu C, Carsote M, Cucu AP, Stanciu M, Popa FL, Ciuche A, Ciobica ML. Primary Cardiac Intimal Sarcoma: Multi-Layered Strategy and Core Role of MDM2 Amplification/Co-Amplification and MDM2 Immunostaining. Diagnostics (Basel) 2024; 14:919. [PMID: 38732333 PMCID: PMC11083306 DOI: 10.3390/diagnostics14090919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2024] [Revised: 04/19/2024] [Accepted: 04/24/2024] [Indexed: 05/13/2024] Open
Abstract
Primary cardiac tumours are relatively uncommon (75% are benign). Across the other 25%, representing malignant neoplasia, sarcomas account for 75-95%, and primary cardiac intimal sarcoma (PCIS) is one of the rarest findings. We aimed to present a comprehensive review and practical considerations from a multidisciplinary perspective with regard to the most recent published data in the specific domain of PCIS. We covered the issues of awareness amid daily practice clinical presentation to ultra-qualified management in order to achieve an adequate diagnosis and prompt intervention, also emphasizing the core role of MDM2 immunostaining and MDM2 genetic analysis. An additional base for practical points was provided by a novel on-point clinical vignette with MDM2-positive status. According to our methods (PubMed database search of full-length, English publications from January 2021 to March 2023), we identified three studies and 23 single case reports represented by 22 adults (male-to-female ratio of 1.2; male population with an average age of 53.75 years, range: 35-81; woman mean age of 55.5 years, range: 34-70) and a 4-year-old child. The tumour-related clinical picture was recognized in a matter of one day to ten months on first admission. These non-specific data (with a very low index of suspicion) included heart failure at least NYHA class II, mitral regurgitation and pulmonary hypertension, acute myocardial infarction, ischemic stroke, obstructive shock, and paroxysmal atrial fibrillation. Awareness might come from other complaints such as (most common) dyspnoea, palpitation, chest pressure, cough, asthenia, sudden fatigue, weakness, malaise, anorexia, weight loss, headache, hyperhidrosis, night sweats, and epigastric pain. Two individuals were initially misdiagnosed as having endocarditis. A history of prior treated non-cardiac malignancy was registered in 3/23 subjects. Distant metastasis as the first step of detection (n = 2/23; specifically, brain and intestinal) or during follow-up (n = 6/23; namely, intestinal, brain and bone, in two cases for each, and adrenal) required additional imagery tools (26% of the patients had distant metastasis). Transoesophageal echocardiography, computed tomography (CT), magnetic resonance imagery, and even 18F-FDG positronic emission tomography-CT (which shows hypermetabolic lesions in PCIS) represent the basis of multimodal tools of investigation. Tumour size varied from 3 cm to ≥9 cm (average largest diameter of 5.5 cm). The most frequent sites were the left atrium followed by the right ventricle and the right atrium. Post-operatory histological confirmation was provided in 20/23 cases and, upon tumour biopsy, in 3/23 of them. The post-surgery maximum free-disease interval was 8 years, the fatal outcome was at the earliest two weeks since initial admission. MDM2 analysis was provided in 7/23 subjects in terms of MDM2-positive status (two out of three subjects) at immunohistochemistry and MDM2 amplification (four out of five subjects) at genetic analysis. Additionally, another three studies addressed PCISs, and two of them offered specific MDM2/MDM2 assays (n = 35 patients with PCISs); among the provided data, we mention that one cohort (n = 20) identified a rate of 55% with regard to MDM2 amplification in intimal sarcomas, and this correlated with a myxoid pattern; another cohort (n = 15) showed that MDM2-positive had a better prognostic than MDM2-negative immunostaining. To summarize, MDM2 amplification and co-amplification, for example, with MDM4, CDK4, HMGA3, CCND3, PDGFRA, TERT, KIT, CCND3, and HDAC9, might improve the diagnosis of PCIS in addition to MDM2 immunostaining since 10-20% of these tumours are MDM2-negative. Further studies are necessary to highlight MDM2 applicability as a prognostic factor and as an element to be taken into account amid multi-layered management in an otherwise very aggressive malignancy.
Collapse
Affiliation(s)
- Claudiu Nistor
- Department 4-Cardio-Thoracic Pathology, Thoracic Surgery II Discipline, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania; (C.N.); (A.C.)
- Thoracic Surgery Department, “Dr. Carol Davila” Central Military Emergency University Hospital, 010242 Bucharest, Romania; (C.S.G.); (A.-P.C.)
| | - Camelia Stanciu Gavan
- Thoracic Surgery Department, “Dr. Carol Davila” Central Military Emergency University Hospital, 010242 Bucharest, Romania; (C.S.G.); (A.-P.C.)
| | - Adelina Birceanu
- Pathology and Immunohistochemistry Laboratory, Pathoteam Diagnostic, 051923 Bucharest, Romania;
| | - Cezar Betianu
- Department of Interventional Imaging, “Doctor Carol Davila” Central Military Emergency University Hospital, 010825 Bucharest, Romania;
| | - Mara Carsote
- Department of Endocrinology, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
- Department of Clinical Endocrinology V, C.I. Parhon National Institute of Endocrinology, 020021 Bucharest, Romania
| | - Anca-Pati Cucu
- Thoracic Surgery Department, “Dr. Carol Davila” Central Military Emergency University Hospital, 010242 Bucharest, Romania; (C.S.G.); (A.-P.C.)
- PhD Doctoral School, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania
| | - Mihaela Stanciu
- Department of Endocrinology, Faculty of Medicine, “Lucian Blaga” University of Sibiu, 550024 Sibiu, Romania;
| | - Florina Ligia Popa
- Department of Physical Medicine and Rehabilitation, Faculty of Medicine, “Lucian Blaga” University of Sibiu, 550024 Sibiu, Romania;
| | - Adrian Ciuche
- Department 4-Cardio-Thoracic Pathology, Thoracic Surgery II Discipline, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania; (C.N.); (A.C.)
- Thoracic Surgery Department, “Dr. Carol Davila” Central Military Emergency University Hospital, 010242 Bucharest, Romania; (C.S.G.); (A.-P.C.)
| | - Mihai-Lucian Ciobica
- Department of Internal Medicine and Gastroenterology, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania;
- Department of Internal Medicine I and Rheumatology, “Dr. Carol Davila” Central Military University Emergency Hospital, 010825 Bucharest, Romania
| |
Collapse
|
3
|
Fan J, Perez C, Widmer RJ, Nguyen V, Zhou G, Wahab L, Banchs JE. Intracardiac Ultrasound and Mapping Integration-Guided Endomyocardial Biopsy for the Diagnosis of Myocardial Melanoma Metastasis. JACC CardioOncol 2024; 6:325-328. [PMID: 38774002 PMCID: PMC11103031 DOI: 10.1016/j.jaccao.2024.01.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Revised: 01/09/2024] [Accepted: 01/31/2024] [Indexed: 05/24/2024] Open
Affiliation(s)
- Jerry Fan
- Division of Cardiology, Baylor Scott and White Health-Temple, Temple, Texas, USA
| | - Christopher Perez
- Division of Cardiology, Baylor Scott and White Health-Temple, Temple, Texas, USA
| | - Robert J. Widmer
- Division of Cardiology, Baylor Scott and White Health-Temple, Temple, Texas, USA
| | - Vinh Nguyen
- Division of Cardiology, Baylor Scott and White Health-Temple, Temple, Texas, USA
| | - Gang Zhou
- Department of Pathology, Baylor Scott and White Health-Temple, Temple, Texas, USA
| | - Laith Wahab
- Division of Cardiology, Baylor Scott and White Health-Temple, Temple, Texas, USA
| | - Javier E. Banchs
- Division of Cardiology, Baylor Scott and White Health-Temple, Temple, Texas, USA
| |
Collapse
|
4
|
Rogalla P, O'Brien C, Pakkal M, Kandel S, Sarie N, Cusimano RJ, Pourafkari M. CT-Fluoroscopy Guided Percutaneous Biopsy of Cardio-Pericardial Masses. Can Assoc Radiol J 2024; 75:191-195. [PMID: 37530532 DOI: 10.1177/08465371231187873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/03/2023] Open
Affiliation(s)
- Patrik Rogalla
- Joint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada
| | - Ciara O'Brien
- Joint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada
| | - Mini Pakkal
- Joint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada
| | - Sonja Kandel
- Joint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada
| | - Nikta Sarie
- Biomedical Science Undergraduate Student, York University, Toronto, ON, Canada
| | | | - Marina Pourafkari
- Joint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
5
|
Bangolo A, Fwelo P, Iyer KM, Klinger S, Tavares L, Dey S, Chacko AA, Hein M, Gudena S, Lawal G, Sivasubramanian BP, Rimba Z, Hirpara K, Merajunnissa M, Veliginti S, Arana G, Sathyarajan DT, Singh S, Shetty T, Bhardwaj K, Hashemy S, Duran RL, Kim SH, Hipolito CM, Yoon K, Patel V, Alshimari A, Inban P, Yasmeen S, Devanaboyina K, Kumar G, Preet S, Akhtar M, Abdi A, Nalajala N, Rizvi SFM, Gupta B, Weissman S. Primary Cardiac Sarcoma: Clinical Characteristics and Prognostic Factors over the Past 2 Decades. Diseases 2023; 11:diseases11020074. [PMID: 37218887 DOI: 10.3390/diseases11020074] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2023] [Revised: 05/08/2023] [Accepted: 05/12/2023] [Indexed: 05/24/2023] Open
Abstract
BACKGROUND Primary cardiac sarcomas (PCS) are extremely rare malignant tumors involving the heart. Only isolated case reports have been described in the literature over different periods of time. This pathology has been associated with a dismal prognosis and given its rarity; treatment options are very limited. Furthermore, there are contrasting data about the effectiveness of current treatment modalities in improving the survival of patients with PCS, including surgical resection which is the mainstay of therapy. There is a paucity of data on the epidemiological characteristics of PCS. This study has the objective of investigating the epidemiologic characteristics, survival outcomes, and independent prognostic factors of PCS. METHODS A total of 362 patients were ultimately registered in our study from the Surveillance, Epidemiology, and End Results (SEER) database. The study period was from 2000 to 2017. Demographics such as clinical characteristics, overall mortality (OM), and PCS-specific mortality (CSM) were taken into account. A p value of <0.1 in the univariate analysis leads to the incorporation of the variable into multivariate analysis adjusting for covariates. Adverse prognostic factors were represented by a Hazard Ratio (HR) greater than one. The five-year survival analysis was carried out using the Kaplan-Meier method and the log-rank test was used to compare survival curves. RESULTS Crude analysis revealed a high OM in age 80+ (HR = 5.958, 95% CI 3.357-10.575, p < 0.001), followed by age 60-79 (HR = 1.429, 95% CI 1.028-1.986, p = 0.033); and PCS with distant metastases (HR = 1.888, 95% CI 1.389-2.566, p < 0.001). Patients that underwent surgical resection of the primary tumor and patients with malignant fibrous histiocytomas (HR = 0.657, 95% CI 0.455-0.95, p = 0.025) had a better OM (HR = 0.606, 95% CI 0.465-0.791, p < 0.001). The highest cancer-specific mortality was observed in age 80+ (HR = 5.037, 95% CI 2.606-9.736, p < 0.001) and patients with distant metastases (HR = 1.953, 95% CI 1.396-2.733, p < 0.001). Patients with malignant fibrous histiocytomas (HR = 0.572, 95% CI 0.378-0.865, p = 0.008) and those who underwent surgery (HR = 0.581, 95% CI 0.436-0.774, p < 0.001) had a lower CSM. Patients in the age range 80+ (HR = 13.261, 95% CI 5.839-30.119, p < 0.001) and advanced disease with distant metastases (HR = 2.013, 95% CI 1.355-2.99, p = 0.001) were found to have a higher OM in the multivariate analyses adjusting for covariates). Lower OM was found in patients with rhabdomyosarcoma (HR = 0.364, 95% CI 0.154-0.86, p = 0.021) and widowed patients (HR = 0.506, 95% CI 0.263-0.977, p = 0.042). Multivariate cox proportional hazard regression analyses of CSM also revealed higher mortality of the same groups, and lower mortality in patients with Rhabdomyosarcoma. CONCLUSION In this United States population-based retrospective cohort study using the SEER database, we found that cardiac rhabdomyosarcoma was associated with the lowest CSM and OM. Furthermore, as expected, age and advanced disease at diagnosis were independent factors predicting poor prognosis. Surgical resection of the primary tumor showed lower CSM and OM in the crude analysis but when adjusted for covariates in the multivariate analysis, it did not significantly impact the overall mortality or the cancer-specific mortality. These findings allow for treating clinicians to recognize patients that should be referred to palliative/hospice care at the time of diagnosis and avoid any surgical interventions as they did not show any differences in mortality. Surgical resection, adjuvant chemotherapy, and/or radiation in patients with poor prognoses should be reserved as palliative measures rather than an attempt to cure the disease.
Collapse
Affiliation(s)
- Ayrton Bangolo
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Pierre Fwelo
- Department of Epidemiology, Human Genetics, and Environmental Sciences, UTHealth School of Public Health, Houston, TX 77030, USA
| | - Kritika M Iyer
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Sarah Klinger
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Lorena Tavares
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Shraboni Dey
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Angel Ann Chacko
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Myat Hein
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Samyukta Gudena
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Gbenga Lawal
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Barath P Sivasubramanian
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Zekordavar Rimba
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Kinjal Hirpara
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Merajunnissa Merajunnissa
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Swathi Veliginti
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Georgemar Arana
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Dily T Sathyarajan
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Sachin Singh
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Tanvi Shetty
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Kshitij Bhardwaj
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Sayed Hashemy
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Roberto L Duran
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Sung H Kim
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Candice M Hipolito
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Kibo Yoon
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Vrusha Patel
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Aseel Alshimari
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Pugazhendi Inban
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Saaniya Yasmeen
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Krushika Devanaboyina
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Gulshan Kumar
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Saran Preet
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Mishgan Akhtar
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Ayanleh Abdi
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Navya Nalajala
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Syed F M Rizvi
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Bhavna Gupta
- Department of Hematology and Oncology, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| | - Simcha Weissman
- Department of Medicine, Hackensack Meridian Health/Palisades Medical Center, North Bergen, NJ 07047, USA
| |
Collapse
|
6
|
Woods MA, Knavel Koepsel EM, Swietlik JF, Shin DS, Chick JFB, Weaver JJ, Watts MM, Laeseke P, Kleedehn MG, Monroe EJ. Intravascular US: Applications in Interventional Radiology. Radiographics 2022; 42:1742-1757. [PMID: 36190846 DOI: 10.1148/rg.220015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Interventional radiology applications of intravascular US (IVUS) continue to expand, complementing intraprocedural angiography and providing a unique vantage from which to guide endovascular interventions. Vascular pathologic conditions become sonographically visualized rather than inferred from the planar appearance of the opacified vascular lumen. Perivascular targets become sonographically visualized rather than approximated on the basis of fluoroscopic landmarks. The authors introduce broad categories of IVUS catheters, namely radial and side-firing varieties, as well as prevailing options for each and their technical specifications. Common applications within interventional radiology are covered in a systems approach, including deep venous thrombosis, May-Thurner syndrome, nutcracker syndrome, transjugular intrahepatic portosystemic shunts, aortic interventions, peripheral arterial disease, and endovascular or perivascular biopsy. Discussions are accompanied by technical pearls from the authors, and summarized evidence where IVUS has been shown to reduce procedural time, intravascular contrast agent dose, radiation exposure, and morbidity in each space is presented. Finally, emerging applications and future directions are discussed. ©RSNA, 2022.
Collapse
Affiliation(s)
- Michael A Woods
- From the Department of Radiology, Section of Vascular and Interventional Radiology, University of Wisconsin, 600 Highland Ave, Madison, WI 53792 (M.A.W., E.M.K.K., J.F.S., P.L., M.G.K., E.J.M.); Department of Radiology, Section of Vascular and Interventional Radiology (D.S.S., J.F.B.C., J.J.W.), and Deep Vein Institute (D.S.S., J.F.B.C.), University of Washington, Seattle, Wash; and Atlantic Medical Imaging Vascular Institute, Vineland, NJ (M.M.W.)
| | - Erica M Knavel Koepsel
- From the Department of Radiology, Section of Vascular and Interventional Radiology, University of Wisconsin, 600 Highland Ave, Madison, WI 53792 (M.A.W., E.M.K.K., J.F.S., P.L., M.G.K., E.J.M.); Department of Radiology, Section of Vascular and Interventional Radiology (D.S.S., J.F.B.C., J.J.W.), and Deep Vein Institute (D.S.S., J.F.B.C.), University of Washington, Seattle, Wash; and Atlantic Medical Imaging Vascular Institute, Vineland, NJ (M.M.W.)
| | - John F Swietlik
- From the Department of Radiology, Section of Vascular and Interventional Radiology, University of Wisconsin, 600 Highland Ave, Madison, WI 53792 (M.A.W., E.M.K.K., J.F.S., P.L., M.G.K., E.J.M.); Department of Radiology, Section of Vascular and Interventional Radiology (D.S.S., J.F.B.C., J.J.W.), and Deep Vein Institute (D.S.S., J.F.B.C.), University of Washington, Seattle, Wash; and Atlantic Medical Imaging Vascular Institute, Vineland, NJ (M.M.W.)
| | - David S Shin
- From the Department of Radiology, Section of Vascular and Interventional Radiology, University of Wisconsin, 600 Highland Ave, Madison, WI 53792 (M.A.W., E.M.K.K., J.F.S., P.L., M.G.K., E.J.M.); Department of Radiology, Section of Vascular and Interventional Radiology (D.S.S., J.F.B.C., J.J.W.), and Deep Vein Institute (D.S.S., J.F.B.C.), University of Washington, Seattle, Wash; and Atlantic Medical Imaging Vascular Institute, Vineland, NJ (M.M.W.)
| | - Jeffrey Forris Beecham Chick
- From the Department of Radiology, Section of Vascular and Interventional Radiology, University of Wisconsin, 600 Highland Ave, Madison, WI 53792 (M.A.W., E.M.K.K., J.F.S., P.L., M.G.K., E.J.M.); Department of Radiology, Section of Vascular and Interventional Radiology (D.S.S., J.F.B.C., J.J.W.), and Deep Vein Institute (D.S.S., J.F.B.C.), University of Washington, Seattle, Wash; and Atlantic Medical Imaging Vascular Institute, Vineland, NJ (M.M.W.)
| | - John J Weaver
- From the Department of Radiology, Section of Vascular and Interventional Radiology, University of Wisconsin, 600 Highland Ave, Madison, WI 53792 (M.A.W., E.M.K.K., J.F.S., P.L., M.G.K., E.J.M.); Department of Radiology, Section of Vascular and Interventional Radiology (D.S.S., J.F.B.C., J.J.W.), and Deep Vein Institute (D.S.S., J.F.B.C.), University of Washington, Seattle, Wash; and Atlantic Medical Imaging Vascular Institute, Vineland, NJ (M.M.W.)
| | - Micah M Watts
- From the Department of Radiology, Section of Vascular and Interventional Radiology, University of Wisconsin, 600 Highland Ave, Madison, WI 53792 (M.A.W., E.M.K.K., J.F.S., P.L., M.G.K., E.J.M.); Department of Radiology, Section of Vascular and Interventional Radiology (D.S.S., J.F.B.C., J.J.W.), and Deep Vein Institute (D.S.S., J.F.B.C.), University of Washington, Seattle, Wash; and Atlantic Medical Imaging Vascular Institute, Vineland, NJ (M.M.W.)
| | - Paul Laeseke
- From the Department of Radiology, Section of Vascular and Interventional Radiology, University of Wisconsin, 600 Highland Ave, Madison, WI 53792 (M.A.W., E.M.K.K., J.F.S., P.L., M.G.K., E.J.M.); Department of Radiology, Section of Vascular and Interventional Radiology (D.S.S., J.F.B.C., J.J.W.), and Deep Vein Institute (D.S.S., J.F.B.C.), University of Washington, Seattle, Wash; and Atlantic Medical Imaging Vascular Institute, Vineland, NJ (M.M.W.)
| | - Mark G Kleedehn
- From the Department of Radiology, Section of Vascular and Interventional Radiology, University of Wisconsin, 600 Highland Ave, Madison, WI 53792 (M.A.W., E.M.K.K., J.F.S., P.L., M.G.K., E.J.M.); Department of Radiology, Section of Vascular and Interventional Radiology (D.S.S., J.F.B.C., J.J.W.), and Deep Vein Institute (D.S.S., J.F.B.C.), University of Washington, Seattle, Wash; and Atlantic Medical Imaging Vascular Institute, Vineland, NJ (M.M.W.)
| | - Eric J Monroe
- From the Department of Radiology, Section of Vascular and Interventional Radiology, University of Wisconsin, 600 Highland Ave, Madison, WI 53792 (M.A.W., E.M.K.K., J.F.S., P.L., M.G.K., E.J.M.); Department of Radiology, Section of Vascular and Interventional Radiology (D.S.S., J.F.B.C., J.J.W.), and Deep Vein Institute (D.S.S., J.F.B.C.), University of Washington, Seattle, Wash; and Atlantic Medical Imaging Vascular Institute, Vineland, NJ (M.M.W.)
| |
Collapse
|
7
|
Seifu SA, Fabbro M, Cohen MG. Cerebral Embolic Protection During Transseptal Biopsy of Left Atrial Mass. JACC Case Rep 2022; 4:955-961. [PMID: 35935161 PMCID: PMC9350902 DOI: 10.1016/j.jaccas.2022.05.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2022] [Revised: 05/12/2022] [Accepted: 05/19/2022] [Indexed: 11/17/2022]
Abstract
Diagnostic biopsy of a left atrial mass is technically feasible but has the risk of tumor embolization causing stroke or seeding. In this case report, we highlight the technical steps for left atrial mass biopsy under transesophageal echocardiography guidance by using cerebral embolic protection. Pathologic examination disclosed low-grade B-cell lymphoma. (Level of Difficulty: Advanced.)
Collapse
|
8
|
Maturu VN, Prasad VP, Vaddepally CR, Sethi S. Endobronchial ultrasound guided intracardiac needle aspiration (EBUS-ICNA). BMJ Case Rep 2022; 15:e249279. [PMID: 35817483 PMCID: PMC9274520 DOI: 10.1136/bcr-2022-249279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/30/2022] [Indexed: 11/03/2022] Open
Abstract
Most cardiac tumours are secondary to metastasis from extracardiac tumours. Obtaining biopsy from intracardiac lesions, especially from the left heart, is challenging, and the conventionally used methods are invasive and involve significant risks such as arrhythmias, tamponade, valvular damage and tumour embolisation. Endobronchial ultrasound (EBUS) is a minimally invasive procedure used to biopsy lymph nodes or mass lesions adjacent to the airways. Its safety and usefulness have been well established. Use of EBUS has expanded to several novel indications over the last few years. Here we report a case of a young woman with suspected metastatic disease to the heart, in whom traditional methods of biopsy had failed to give a diagnosis. EBUS-guided transbronchial intracardiac needle aspiration was safely performed from the left atrial mass lesion to obtain tissue for histopathological diagnosis. A diagnosis of metastatic adenocarcinoma with tumour embolisation to the heart was established.
Collapse
Affiliation(s)
- Venkata Nagarjuna Maturu
- Pulmonary Medicine, Yashoda Super Specialty Hospitals Somajiguda Hyderabad, Hyderabad, Telangana, India
| | - Virender Pratibh Prasad
- Pulmonary Medicine, Yashoda Super Specialty Hospitals Somajiguda Hyderabad, Hyderabad, Telangana, India
| | - Chetan Rao Vaddepally
- Pulmonary Medicine, Yashoda Super Specialty Hospitals Somajiguda Hyderabad, Hyderabad, Telangana, India
| | - Shweta Sethi
- Department of Pathology, Yashoda Super Specialty Hospitals Somajiguda Hyderabad, Hyderabad, Telangana, India
| |
Collapse
|
9
|
Intracardiac echocardiography guidance to increase diagnostic yield of endomyocardial biopsy of a cardiac mass. J Interv Card Electrophysiol 2022; 63:743-744. [DOI: 10.1007/s10840-022-01127-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/06/2021] [Accepted: 01/13/2022] [Indexed: 11/25/2022]
|